United States · FDA National Drug Code directory
Epclusa
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 61958-2204_4e28b652-df20-450d-9f6e-4cc6e355e223
- Product NDC
- 61958-2204
- Form
- PELLET
- Composition / generic term
- Velpatasvir and Sofosbuvir
- Labeler
- Gilead Sciences, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20210610
- Source listing expiry
- 20261231
Source-listed ingredients
- VELPATASVIR — 50 mg/1
- SOFOSBUVIR — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 28 PACKET in 1 CARTON (61958-2204-1) / 1 PELLET in 1 PACKET · 61958-2204-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →